These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30335349)

  • 1. In Vivo Modulation of Hippocampal Excitability by M4 Muscarinic Acetylcholine Receptor Activator: Implications for Treatment of Alzheimer's Disease and Schizophrenic Patients.
    Popiolek M; Mandelblat-Cerf Y; Young D; Garst-Orozco J; Lotarski SM; Stark E; Kramer M; Butler CR; Kozak R
    ACS Chem Neurosci; 2019 Mar; 10(3):1091-1098. PubMed ID: 30335349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of Xanomeline.
    Thorn CA; Moon J; Bourbonais CA; Harms J; Edgerton JR; Stark E; Steyn SJ; Butter CR; Lazzaro JT; O'Connor RE; Popiolek M
    ACS Chem Neurosci; 2019 Mar; 10(3):1753-1764. PubMed ID: 30480428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of M1 and M4 activation on excitatory synaptic transmission in CA1.
    Thorn CA; Popiolek M; Stark E; Edgerton JR
    Hippocampus; 2017 Jul; 27(7):794-810. PubMed ID: 28422371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice.
    Tzavara ET; Bymaster FP; Felder CC; Wade M; Gomeza J; Wess J; McKinzie DL; Nomikos GG
    Mol Psychiatry; 2003 Jul; 8(7):673-9. PubMed ID: 12874603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Pharmacological Comparison of TAK-071, a Positive Allosteric Modulator of Muscarinic M
    Mandai T; Kasahara M; Kurimoto E; Tanaka M; Suzuki M; Nakatani A; Kimura H
    Neuroscience; 2019 Aug; 414():60-76. PubMed ID: 31299348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Firing of Theta State-Related Septal Cholinergic Neurons Disrupt Hippocampal Ripple Oscillations via Muscarinic Receptors.
    Ma X; Zhang Y; Wang L; Li N; Barkai E; Zhang X; Lin L; Xu J
    J Neurosci; 2020 Apr; 40(18):3591-3603. PubMed ID: 32265261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission.
    Shirey JK; Xiang Z; Orton D; Brady AE; Johnson KA; Williams R; Ayala JE; Rodriguez AL; Wess J; Weaver D; Niswender CM; Conn PJ
    Nat Chem Biol; 2008 Jan; 4(1):42-50. PubMed ID: 18059262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M
    Butler CR; Popiolek M; McAllister LA; LaChapelle EA; Kramer M; Beck EM; Mente S; Brodney MA; Brown M; Gilbert A; Helal C; Ogilvie K; Starr J; Uccello D; Grimwood S; Edgerton J; Garst-Orozco J; Kozak R; Lotarski S; Rossi A; Smith D; O'Connor R; Lazzaro J; Steppan C; Steyn SJ
    J Med Chem; 2024 Jul; 67(13):10831-10847. PubMed ID: 38888621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M4 muscarinic receptors are involved in modulation of neurotransmission at synapses of Schaffer collaterals on CA1 hippocampal neurons in rats.
    Sánchez G; Alvares Lde O; Oberholzer MV; Genro B; Quillfeldt J; da Costa JC; Cerveñansky C; Jerusalinsky D; Kornisiuk E
    J Neurosci Res; 2009 Feb; 87(3):691-700. PubMed ID: 18816796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M(1) and M(4) muscarinic acetylcholine receptors agonists.
    Uruno Y; Konishi Y; Suwa A; Takai K; Tojo K; Nakako T; Sakai M; Enomoto T; Matsuda H; Kitamura A; Sumiyoshi T
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5357-61. PubMed ID: 26428869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice.
    Zhang W; Basile AS; Gomeza J; Volpicelli LA; Levey AI; Wess J
    J Neurosci; 2002 Mar; 22(5):1709-17. PubMed ID: 11880500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases.
    Felder CC; Goldsmith PJ; Jackson K; Sanger HE; Evans DA; Mogg AJ; Broad LM
    Neuropharmacology; 2018 Jul; 136(Pt C):449-458. PubMed ID: 29374561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100.
    Byun NE; Grannan M; Bubser M; Barry RL; Thompson A; Rosanelli J; Gowrishankar R; Kelm ND; Damon S; Bridges TM; Melancon BJ; Tarr JC; Brogan JT; Avison MJ; Deutch AY; Wess J; Wood MR; Lindsley CW; Gore JC; Conn PJ; Jones CK
    Neuropsychopharmacology; 2014 Jun; 39(7):1578-93. PubMed ID: 24442096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M(4) muscarinic acetylcholine receptor agonists.
    Suwa A; Konishi Y; Uruno Y; Takai K; Nakako T; Sakai M; Enomoto T; Ochi Y; Matsuda H; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2909-12. PubMed ID: 24852118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition.
    Elvander E; Schött PA; Sandin J; Bjelke B; Kehr J; Yoshitake T; Ogren SO
    Neuroscience; 2004; 126(3):541-57. PubMed ID: 15183504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insular muscarinic signaling regulates anxiety-like behaviors in rats on the elevated plus-maze.
    Li H; Chen L; Li P; Wang X; Zhai H
    Behav Brain Res; 2014 Aug; 270():256-60. PubMed ID: 24844754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of muscarinic receptors during blockade of GABA(A)-mediated inhibition induces synchronous epileptiform activity in immature rat hippocampus.
    Psarropoulou C; Dallaire F
    Neuroscience; 1998 Feb; 82(4):1067-77. PubMed ID: 9466430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of muscarinic M
    Stoll K; Hart R; Lindsley CW; Thomsen M
    Psychopharmacology (Berl); 2018 Mar; 235(3):815-827. PubMed ID: 29250738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic acetylcholine M
    Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
    Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia.
    Barak S; Weiner I
    Int J Neuropsychopharmacol; 2011 Oct; 14(9):1233-46. PubMed ID: 21211109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.